About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Austin | 7,650 Studies Near You

Clinical TrialsAustin

Clinical Trials in Austin

Discover 7,650 clinical trials near Austin, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5721-5740 of 7,650 trials

CompletedICU Recovery in Australian PatientsIncreasingly patients with critical illness requiring life support in an intensive care unit are surviving their hospital admission.NCT02225938·Clayton, Victoria and 4 others UnknownPaclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial CancerThis randomized phase II/III trial studies how well paclitaxel, carboplatin, and metformin hydrochloride works and compares it to paclitaxel, carboplatin, and placebo in treating…NCT02065687·Birmingham, Alabama and 430 others

Find Trials by Condition in Austin

Breast Cancerin Austin Lung Cancerin Austin Prostate Cancerin Austin Colorectal Cancerin Austin Melanomain Austin Leukemiain Austin Lymphomain Austin Pancreatic Cancerin Austin Ovarian Cancerin Austin Brain Cancerin Austin Diabetesin Austin

Data from ClinicalTrials.govTerms

TerminatedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated MelanomaThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03727087·Little Rock, Arkansas and 35 others

WithdrawnA Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose TherapyThis study will evaluate the safety and preliminary efficacy of venetoclax when combined with lenalidomide and dexamethasone for participants with newly diagnosed, active t(11;14)…NCT03785184·Duarte, California and 21 others

CompletedPharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With EpilepsyOpen-label study to assess the pharmacokinetics of a single diazepam buccal film (DBF) dose in 3 age cohorts of pediatric patients with epilepsy (age 2-5 years, age 6-11 years…NCT03222349·Tucson, Arizona and 9 others

RecruitingA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal CancerCRC is the third most common type of cancer diagnosed worldwide with developed countries at highest risk.NCT06820463·Duarte, California and 77 others

CompletedA Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19The primary objective of this study is to describe the longevity of IgG against SARS-CoV-2 infection or vaccination.NCT05042193·Austin, Texas

TerminatedA Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy ParticipantsThis is an open-label, single-dose, four-period, four sequential, and crossover study conducted to assess the relative bioavailability of GSK3640254 mesylate tablets and…NCT04128293·Austin, Texas

RecruitingPhase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerThis is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 (zovegalisib) + fulvestrant to capivasertib + fulvestrant for the…NCT06982521·Gilbert, Arizona and 242 others

CompletedAMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)The objective of the trial is to demonstrate the safety and effectiveness of the Cardiva Mid-Bore Venous Vascular Closure System (VVCS) in sealing femoral venous access sites at…NCT03573206·Atlanta, Georgia and 2 others

RecruitingStudy to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseaseThis is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.NCT06808984·Homewood, Alabama and 76 others

CompletedA Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 MonthsTOL-CLAR-20024 is a Phase 4, multi-center, open-label safety study evaluating the potential effect of JATENZO on adrenal function in hypogonadal men treated with JATENZO for 12…NCT06385509·Tempe, Arizona and 26 others

CompletedDose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus RilpivirineThe study is designed to select a dose of GSK1265744 primarily on the basis of antiviral activity and tolerability in HIV-1 infected, antiretroviral naive subjects.NCT01641809·Birmingham, Alabama and 47 others

CompletedLong-term Safety Study of Glycopyrronium in Subjects With Primary Axillary HyperhidrosisThis is an open-label, long-term safety study of glycopyrronium topical wipes, enrolling up to 660 subjects with primary axillary hyperhidrosis who participated in either the…NCT02553798·Mobile, Alabama and 47 others

TerminatedStudy of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)The purpose of this study was to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of MK-6552 in participants with Narcolepsy Type 1 (NT1).NCT06179407·Colorado Springs, Colorado and 4 others

CompletedFasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the KneeThis study is designed as a double-blind, randomised, placebo-controlled, four parallel arm, dose-finding study, to be conducted in approximately 26 sites, to evaluate the…NCT02205814·Tucson, Arizona and 24 others

CompletedStudy of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaThe purpose of the protocol is to evaluate the efficacy of olanzapine compared with Aripiprazole in patients with schizophrenia.NCT00088049·Little Rock, Arkansas and 23 others

CompletedSafety and Efficacy of ACU-D1 in the Treatment of Acne RosaceaThe study evaluated the safety, tolerability, and efficacy of ACCU-D1 when applied twice daily for 12 weeks in adult participants with moderate to severe acne rosacea.NCT03064438·Louisville, Kentucky and 1 other

CompletedA Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy SurgeryThe purpose of this study is to evaluate the effectiveness (level of pain control) and safety of the administration of 2 different dose levels of Extended Release…NCT00404391·Owing Mills, Maryland and 3 others

CompletedAn Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of MigraineThis study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.NCT02873221·Birmingham, Alabama and 176 others

PreviousPage 287 of 383Next

Heart Diseasein Austin